Medline to complete $20M expansion of flush manufacturing facilities

Northfield, Ill.-based Medline will invest $20 million to expand its flush manufacturing plants in Wisconsin and New Jersey. 

The expansion will help broaden the company's portfolio of SwabFlush products to reflect an increasing amount of demand in the flush syringe market.

SwabFlush is an IV catheter flush syringe that contains a disinfection cap for needleless IV connectors.

"Infection prevention is a key focus for health systems across the care continuum and it is crucial that Medline is able to provide effective solutions that enhance their initiatives," said Dante Tisci, president of Medline's Dynacor division, in a news release. "By enhancing and expanding our SwabFlush product line, Medline can better meet our customers' demands for reducing the rate of infection and containing costs."

More articles on supply chain:

Healthcare Supply Chain ranks Intermountain Healthcare #1 in nation
Corporate supply chains produce $906B in annual revenue linked to deforestation
Why this Supreme Court patent case may have expensive implications for device manufacturers


Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars